EUVIMEDEUVIMED entdecken
Crossref

Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy

Yang Sun, Long Jin, Jia-Hua Liu, Yu-Xia Sui, Li-Li Han, Xiao-Li Shen

Cancer Biotherapy and Radiopharmaceuticals · 2016-09 · 31 (7) · 246-252

DOI: 10.1089/cbr.2016.2034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2016-09. Verfasst von Yang Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Gynecology, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsApoptosisAutophagyCell Line, TumorCisplatinDrug Resistance, NeoplasmEnhancer of Zeste Homolog 2 ProteinFemaleGene ExpressionHumansOvarian NeoplasmsTransfection

Stichwörter der Autor:innen

EZH2autophagycisplatinovarian cancer

Substanzen

Antineoplastic AgentsEZH2 protein, humanEnhancer of Zeste Homolog 2 ProteinCisplatin

Autor:innen und Institutionen

  • 1 Department of Gynecology, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China .
  • 2 Department of Pathology, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China .
  • 3 Department of Pharmacy, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China .
  • 4 Fujian Provincial Key Laboratory of Cardiovascular Disease, Fujian Provincial Hospital, Fujian Medical University , Fuzhou, China .

Zitieren

APA

Sun, Y., Jin, L., Liu, J. H., Sui, Y. X., Han, L. L., & Shen, X. L. (2016). Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy. Cancer Biotherapy and Radiopharmaceuticals, 31(7), 246-252. https://doi.org/10.1089/cbr.2016.2034

Vancouver

Sun Y, Jin L, Liu JH, Sui YX, Han LL, Shen XL. Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy. Cancer Biotherapy and Radiopharmaceuticals. 2016;31(7):246-252. doi:10.1089/cbr.2016.2034

BibTeX
@article{Sun2016,
  author = {Sun, Yang and Jin, Long and Liu, Jia-Hua and Sui, Yu-Xia and Han, Li-Li and Shen, Xiao-Li},
  title = {Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2016},
  volume = {31},
  number = {7},
  pages = {246--252},
  doi = {10.1089/cbr.2016.2034}
}
Kostenlos starten →